Cargando…

Antibiotic Rotation for Febrile Neutropenic Patients with Hematological Malignancies: Clinical Significance of Antibiotic Heterogeneity

BACKGROUND: Our unit adopted the single administration of cefepime as the initial treatment for febrile episodes in neutropenic patients with hematological malignancies. However, recently, cefepime-resistant gram-negative bacteremia, including those with extended-spectrum β-lactamase (ESBL)-producer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chong, Yong, Shimoda, Shinji, Yakushiji, Hiroko, Ito, Yoshikiyo, Miyamoto, Toshihiro, Kamimura, Tomohiko, Shimono, Nobuyuki, Akashi, Koichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3553165/ https://www.ncbi.nlm.nih.gov/pubmed/23372683 http://dx.doi.org/10.1371/journal.pone.0054190

Ejemplares similares

Clinical Impact of Fluoroquinolone-Resistant Escherichia coli in the Fecal Flora of Hematological Patients with Neutropenia and Levofloxacin Prophylaxis
por: Chong, Yong, et al.
Publicado: (2014)

Incomplete recovery of the fecal flora of hematological patients with neutropenia and repeated fluoroquinolone prophylaxis
por: Chong, Yong, et al.
Publicado: (2017)

Strategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination
por: de Marie, S., et al.
Publicado: (1993)

Antibiotic-Resistant Gram-Negative Bacteremia in Febrile Neutropenic Children
por: Lee, Jina
Publicado: (2016)

Increase in Antibiotic-Resistant Gram-Negative Bacterial Infections in Febrile Neutropenic Children
por: Lee, Joon Hee, et al.
Publicado: (2016)

Efficacy and Safety of Caspofungin Treatment in Febrile Neutropenic Patients with Hematological Disorders: A Multicenter Consecutive Case Series
por: Itoh, Kazuhiro, et al.
Publicado: (2022)

Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode
por: Demirel, Aslıhan, et al.
Publicado: (2015)

Preemptive Antifungal Therapy for Febrile Neutropenic Hematological Malignancy Patients in China
por: Yuan, Wei, et al.
Publicado: (2016)

The relationship between mortality and microbiological parameters in febrile neutropenic patients with hematological malignancies
por: Çalık, Şebnem, et al.
Publicado: (2018)

Classification of Chemotherapy-Induced Febrile Neutropenic Episodes Into One of the Three Febrile Neutropenic Syndromes
por: Raheja, Ronak, et al.
Publicado: (2023)

The cost-effectiveness of empirical antibiotic treatments for high-risk febrile neutropenic patients: A decision analytic model
por: Tori, Katerina, et al.
Publicado: (2020)

The Impact of Modifying Empirical Antibiotic Therapy Based on Intestinal Colonization Status on Clinical Outcomes of Febrile Neutropenic Patients
por: Alrstom, Ali, et al.
Publicado: (2021)

Pharmacist-Driven Antibiotic Stewardship Program in Febrile Neutropenic Patients: A Single Site Prospective Study in Thailand
por: Jantarathaneewat, Kittiya, et al.
Publicado: (2021)

Risk Factors Associated with Stenotrophomonas maltophilia Bacteremia: A Matched Case-Control Study
por: Sumida, Kosuke, et al.
Publicado: (2015)

Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan
por: Koh, Hideo, et al.
Publicado: (2013)

Distinct Inflammatory Mediator Patterns Characterize Infectious and Sterile Systemic Inflammation in Febrile Neutropenic Hematology Patients
por: Wennerås, Christine, et al.
Publicado: (2014)

Micafungin compared with caspofungin for the treatment of febrile episodes in neutropenic patients with hematological malignancies: A retrospective study
por: Shalhoub, Sarah, et al.
Publicado: (2014)

466 Skin lesions in febrile neutropenic patients
por: Yemisen, Mucahit, et al.
Publicado: (2014)

Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study
por: Kim, Hyo Sup, et al.
Publicado: (2017)

The strategy of antibiotic use in critically ill neutropenic patients
por: Legrand, Matthieu, et al.
Publicado: (2011)

Machine Learning to Assess the Risk of Multidrug-Resistant Gram-Negative Bacilli Infections in Febrile Neutropenic Hematological Patients
por: Garcia-Vidal, Carolina, et al.
Publicado: (2021)

Augmented Renal Clearance and Hypoalbuminemia-Induced Low Vancomycin Trough Concentrations in Febrile Neutropenic Patients With Hematological Malignancies
por: Alzahrani, Abdullah M, et al.
Publicado: (2022)

Helicobacter cinaedi Bacteremia Mimicking a Flare of Systemic Lupus Erythematosus
por: Nishida, Ruriko, et al.
Publicado: (2017)

Food-borne bacteremic illnesses in febrile neutropenic children
por: Lee, Anselm Chi-wai, et al.
Publicado: (2011)

Empiric Vancomycin Use in Febrile Neutropenic Oncology Patients
por: Libuit, Jessica, et al.
Publicado: (2014)

Respiratory Viruses in Febrile Neutropenic Patients with Respiratory Symptoms
por: Meidani, Mohsen, et al.
Publicado: (2018)

Candidemia in Febrile Neutropenic Patients; a Brief Report
por: Yousefi, Maysam, et al.
Publicado: (2018)

Febrile neutropenia: significance of elaborated screening for respiratory viruses, and the comparison of different sampling methods, in neutropenic patients with hematological malignancies
por: Jansen, Rogier R, et al.
Publicado: (2013)

Evaluation of febrile neutropenic episodes in adult patients with solid tumors
por: YAPICI, OKTAY, et al.
Publicado: (2016)

Emergency department disposition of non‐neutropenic febrile patients with cancer
por: Bischof, Jason J., et al.
Publicado: (2021)

Prevalence of multidrug-resistant Gram-negative pathogens isolated from febrile neutropenic cancer patients with bloodstream infections in Egypt and new synergistic antibiotic combinations
por: Tohamy, Sally Tohamy, et al.
Publicado: (2018)

P1529: SYSTEMATIC REVIEW OF THE SHORT-TERM VERSUS LONG-TERM DURATION OF ANTIBIOTIC MANAGEMENT FOR NEUTROPENIC FEVER IN PATIENTS WITH HEMATOLOGICAL MALIGNANCY
por: Ishikawa, Kazuhiro, et al.
Publicado: (2023)

Bloodstream infections and mortality-related factors in febrile neutropenic cancer patients
por: Horasan, Elif Sahin, et al.
Publicado: (2011)

Fluoroquinolone resistance in bacteremic and low risk febrile neutropenic patients with cancer
por: Zhang, Sheng, et al.
Publicado: (2015)

Neutropenic Fever in Lung Cancer: Clinical Aspects Related to Mortality and Antibiotic Failure
por: RODRIGUES, Inês, et al.
Publicado: (2021)

Antibiotic practice and stewardship in the management of neutropenic fever: A survey of US institutions
por: Arya, Swarn, et al.
Publicado: (2023)

Prevention of febrile neutropenia: use of prophylactic antibiotics
por: Cullen, M, et al.
Publicado: (2009)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)

Breakthrough candidemia with hematological disease: Results from a single-center retrospective study in Japan, 2009–2020
por: Nishida, Ruriko, et al.
Publicado: (2023)

Plasma levels of procalcitonin and eight additional inflammatory molecules in febrile neutropenic patients
por: Neuenschwander, Letícia Carvalho, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_bs754641j7s0jiuooi90fgvviq